Aspirin could combat permanent hearing loss caused by cancer drug
A new Cancer Research UK trial, involving the University of Southampton, investigating whether high doses of aspirin can help prevent permanent hearing loss, a common side effect among cancer patients given the chemotherapy drug cisplatin, launches today (8 May).
